A. Mieke Timmermans

877 citations

15 papers · 629 indexed · h-index 11

Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
Oncology top 10%
- Cancer Cells and Metastasis 5
- CAR-T cell therapy research 2
- HER2/EGFR in Cancer Research 2
Molecular Biology
- Molecular Biology Techniques and Applications 2
- Epigenetics and DNA Methylation 2
Spectroscopy top 10%
- Advanced Proteomics Techniques and Applications 2
Immunology
- Immunotherapy and Immune Responses 2

Co-authors: John W.M. Martens John A. Foekens Stefan Sleijfer Marcel Smid Reno Debets Maxime P. Look Dora Hammerl Arzu Umar
Cited by: Cancer Research Oncology Molecular Biology
Partner nations: Netherlands Denmark United States

In The Last Decade

A. Mieke Timmermans

13 papers receiving 613 citations

Peers

Countries citing papers authored by A. Mieke Timmermans

Since Specialization

Citations

This map shows the geographic impact of A. Mieke Timmermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mieke Timmermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mieke Timmermans more than expected).

Fields of papers citing papers by A. Mieke Timmermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mieke Timmermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mieke Timmermans. The network helps show where A. Mieke Timmermans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Mieke Timmermans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Mieke Timmermans Line = papers co-authored together A. Mieke Timmermans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive disease Maartje A. C. Schreurs,A. Mieke Timmermans,Michael A. Carpenter,Marcel Smid,Michael A. den Bakker,Carolien H. M. van Deurzen,Reuben S. Harris,John W.M. Martens	2025	0
2	CD3xHER2 bsAb‐Mediated Activation of Resting T‐cells at HER2 Positive Tumor Clusters Is Sufficient to Trigger Bystander Eradication of Distant HER2 Negative Clusters Through IFNγ and TNFα Chen‐Yi Liao,Patrick Engelberts,Michiel van Dijk,A. Mieke Timmermans,John W. M. Martens,Elsa Neubert,Erik H.J. Danen	2025	0
3	Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation Shuoying Qu,A. Mieke Timmermans,Bernadette A. M. Heemskerk‐Gerritsen,Anita Trapman-Jansen,Renée Broeren-Foekens,Wendy J. C. Prager‐van der Smissen,Hoesna El Hassnaoui,Tim van Tienhoven,Claudia K. Bes-Stobbe,Pieter J. Westenend,Carolien H. M. van Deurzen,John W.M. Martens,Maartje J. Hooning,Antoinette Hollestelle	2023	3
4	HER2-low breast cancer shows a lower immune response compared to HER2-negative cases Nadine S. van den Ende,Marcel Smid,A. Mieke Timmermans,Johannes Bastiaan van Brakel,Tim Hansum,Renée Foekens,Anita M.A.C. Trapman,B.A.M. Heemskerk-Gerritsen,Agnes Jager,John W.M. Martens,Carolien H. M. van Deurzen	2022	30
5	Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer Anna E.M. Bastiaansen,A. Mieke Timmermans,Marcel Smid,Carolien H. M. van Deurzen,Esther Hulsenboom,Wendy J. C. Prager‐van der Smissen,Renée Foekens,Anita Trapman-Jansen,Peter A.E. Sillevis Smitt,Theo M. Luider,John W.M. Martens,Martijn M. VanDuijn	2020	12
6	Breast cancer genomics and immuno-oncological markers to guide immune therapies Dora Hammerl,Marcel Smid,A. Mieke Timmermans,Stefan Sleijfer,John W.M. Martens,Reno Debets	2017	115
7	Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients Ning Qing Liu,Tommaso De Marchi,A. Mieke Timmermans,Anita Trapman-Jansen,Renée Foekens,Maxime P. Look,Marcel Smid,Carolien H. M. van Deurzen,Paul N. Span,Fred C.G.J. Sweep,Julie Benedicte Brask,Vera Timmermans‐Wielenga,John A. Foekens,John W.M. Martens,Arzu Umar	2016	16
8	Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant Wies van Roosmalen,Sylvia E. Le Dévédec,Ofra Golani,Marcel Smid,Irina Pulyakhina,A. Mieke Timmermans,Maxime P. Look,Di Zi,Chantal Pont,Marjo de Graauw,Suha Naffar-Abu-Amara,Catherine Kirsanova,Gabriella Rustici,Peter A.C. ’t Hoen,John W.M. Martens,John A. Foekens,Benjamin Geiger,Bob van de Water	2015	98
9	High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer Esther A. Reijm,A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,Claudia Stobbe,Carolien H. M. van Deurzen,John W.M. Martens,Stefan Sleijfer,John A. Foekens,P.M.J.J. Berns,Maurice P.H.M. Jansen	2014	46
10	Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response Ning Qing Liu,Tommaso De Marchi,A. Mieke Timmermans,Robin Beekhof,Anita Trapman-Jansen,Renée Foekens,Maxime P. Look,Carolien H. M. van Deurzen,Paul N. Span,Fred C.G.J. Sweep,Julie Benedicte Brask,Vera Timmermans‐Wielenga,Reno Debets,John W.M. Martens,John A. Foekens,Arzu Umar	2014	47
11	Abstract 806: Extracellular matrix metalloprotease inducer (EMMPRIN) and CD44 protein complexes are exclusively formed in basal- and normal-like breast cancer cell lines A. Mieke Timmermans,Hamed Montazeri,Anita Trapman-Jansen,John W.M. Martens,John A. Foekens,Arzu Umar	2012	1
12	CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes Bianca Mostert,Jaco Kraan,Anieta M. Sieuwerts,Petra van der Spoel,Joan Bolt‐de Vries,Wendy J. C. Prager‐van der Smissen,Marcel Smid,A. Mieke Timmermans,John W.M. Martens,Jan W. Gratama,John A. Foekens,Stefan Sleijfer	2011	41
13	Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 Bianca Mostert,Jaco Kraan,Joan Bolt‐de Vries,Petra van der Spoel,Anieta M. Sieuwerts,Mieke Schutte,A. Mieke Timmermans,Renée Foekens,John W.M. Martens,Jan‐Willem Gratama,John A. Foekens,Stefan Sleijfer	2010	98
14	Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer Arzu Umar,Hyuk Kang,A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,Michael A. den Bakker,Navdeep Jaitly,John W.M. Martens,Theo M. Luider,John A. Foekens,Ljiljana Paša‐Tolić	2009	85
15	Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix‐assisted laser desorption/ionisation‐time of flight and matrix‐assisted laser desorption/ionisation‐time of flight/time of flight‐mass spectrometry Arzu Umar,Johannes C. Dalebout,A. Mieke Timmermans,John A. Foekens,Theo M. Luider	2005	37

About A. Mieke Timmermans

A. Mieke Timmermans is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 15 papers that have together received 629 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Immunotherapy and Immune Responses (2 papers), Molecular Biology Techniques and Applications (2 papers), Epigenetics and DNA Methylation (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (241 citations), Oncology (285 citations) and Molecular Biology (335 citations). A. Mieke Timmermans has collaborated with scholars based in Netherlands, Denmark and United States. Frequent co-authors include John W.M. Martens, John A. Foekens, Stefan Sleijfer, Marcel Smid, Reno Debets, Maxime P. Look, Dora Hammerl, Arzu Umar, Theo M. Luider and Renée Foekens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact